Literature DB >> 7500028

Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids.

F Wang1, T K Sengupta, Z Zhong, L B Ivashkiv.   

Abstract

The balance between type 1 and 2 T helper cell cytokine production plays an important role in several animal models of autoimmunity, and skewed patterns of cytokine expression have been described in human inflammatory diseases. Many cytokines activate signal transducer and activation of transcription (STAT) transcription factors, which, in turn, activate transcription of inflammatory effector genes. We used mononuclear cell priming cultures and inflammatory synovial fluids (SFs) derived from arthritis patients to examine the regulation of cytokine production and STAT activity by an inflammatory synovial microenvironment. Exposure to SFs during priming resulted in an 81% inhibition of interferon (IFN)-gamma, but not interleukin (IL) 4, production by effector cells generated in priming cultures. SF suppression was mediated by IL-4 and IL-10 and inhibition of IL-12 expression, and it was reversed in a dominant fashion by exogenous IL-12. SFs blocked the sustained activity of transcription factor Stat1, but not Stat3, during the priming period, and Stat1 activity was differentially regulated by cytokines in parallel with their positive or negative regulation of IFN-gamma production. Active Stat3, but not Stat1, was detected in cells from inflamed joints. These results suggest a role for altered balance of Stat1 and Stat3 transcriptional activity in the regulation of T cell differentiation and in the pathogenesis of inflammatory synovitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500028      PMCID: PMC2192267          DOI: 10.1084/jem.182.6.1825

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Cytokine measurements in biological fluids.

Authors:  A P Cope; F M Brennan
Journal:  Br J Rheumatol       Date:  1992-11

2.  Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor.

Authors:  G S Firestein; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1987-08

3.  Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity.

Authors:  H M Seidel; L H Milocco; P Lamb; J E Darnell; R B Stein; J Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 4.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

5.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells.

Authors:  L Wen; S J Roberts; J L Viney; F S Wong; C Mallick; R C Findly; Q Peng; J E Craft; M J Owen; A C Hayday
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

7.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

8.  Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.

Authors:  R O Williams; L J Mason; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Immunoregulatory role of interleukin 10 in rheumatoid arthritis.

Authors:  P D Katsikis; C Q Chu; F M Brennan; R N Maini; M Feldmann
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  11 in total

1.  Can SOCS make arthritis better?

Authors:  Lionel B Ivashkiv; Ioannis Tassiulas
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 3.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

4.  Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies.

Authors:  J D Cañete; S E Martínez; J Farrés; R Sanmartí; M Blay; A Gómez; G Salvador; J Muñoz-Gómez
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

5.  The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA).

Authors:  W Kim; S Min; M Cho; J Youn; J Min; S Lee; S Park; C Cho; H Kim; W U Kim; S Y Min; M L Cho; D J Min; S H Lee; S H Park; C S Cho; H Y Kim
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

6.  Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways.

Authors:  Aruna K Behera; Cheleste M Thorpe; J Michael Kidder; Wendy Smith; Ethan Hildebrand; Linden T Hu
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.

Authors:  T K Sengupta; E M Schmitt; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways.

Authors:  Takeo Isozaki; Tsuyoshi Kasama; Ryo Takahashi; Tsuyoshi Odai; Kuninobu Wakabayashi; Hirohito Kanemitsu; Kyoko Nohtomi; Hiroko T Takeuchi; Satoshi Matsukura; Masakazu Tezuka
Journal:  J Inflamm Res       Date:  2008-10-28

9.  Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  Jiro Yamana; Masahiro Yamamura; Akira Okamoto; Tetsushi Aita; Mitsuhiro Iwahashi; Katsue Sunahori; Hirofumi Makino
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

10.  Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.

Authors:  N Macías-Segura; J E Castañeda-Delgado; Y Bastian; D Santiago-Algarra; J D Castillo-Ortiz; A L Alemán-Navarro; E Jaime-Sánchez; M Gomez-Moreno; C A Saucedo-Toral; Edgar E Lara-Ramírez; M Zapata-Zuñiga; L Enciso-Moreno; R González-Amaro; C Ramos-Remus; J A Enciso-Moreno
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.